Overview · Filed: —
ORD_63909/2024
REMOTE MONITORING OF ANALYTE MEASUREMENTS
Procedural & sub-applicationsCase Management OrdersParis LDGeneric Order—
Parties
Claimants
- Dexcom Inc.(Dexcom Group)
Reps: Anne-Charlotte le Bihan (Bird & Bird AARPI); Laurent Labatte (Bird & Bird AARPI); David Sproston (Hoffmann Eitle); Mark Jones (Hoffmann Eitle)
Respondents
- Abbott Logistics B.V.(Abbott Group)
- Abbott Diagnostics GmbH(Abbott Group)
- Abbott France(Abbott Group)
- Abbott Oy(Abbott Group)
- Abbott Diabetes Care Inc.(Abbott Group)
- Newyu, Inc.(Abbott Group)
- Abbott B.V.(Abbott Group)
- Abbott s.r.l.(Abbott Group)
- Abbott Scandinavia Aktiebolag(Abbott Group)
- Abbott Gesellschaft m.b.H.(Abbott Group)
- Abbott Laboratories A/S(Abbott Group)
- Abbott GmbH(Abbott Group)
- Abbott Laboratories(Abbott Group)
Reps: Christian Dekoninck (Taylor Wessing N.V.); François Pochart (August Debouzy)
Judges
French-seated division — individual judges anonymized.
- Panel member (anonymized)Judge-Rapporteur
Patents
- EP3831282
CPC codes: A61B5/7282, A61B5/7465, G16H40/20, H04L67/12, G16H50/70, A61B5/145, G16H40/63, G16H50/20, A61B5/0015, A61B5/0004, A61B5/14532, A61B5/14546…
Sector: Healthcare Informatics
Outcome
Revoked
Filed: —
First decided: Dec 11, 2024
Language: —
Decision on the merits from the Paris Local Division (UPC_CFI_395/2023) delivered on 11 December 2024 in DexCom's infringement action against Abbott entities concerning EP 3 831 282. The Court found the patent invalid in its entirety — neither as granted nor as amended by auxiliary requests 1, 2 or 3 — due to added subject-matter under Art. 138(1)(c) EPC. The infringement action was dismissed for lack of legal basis. DexCom was ordered to bear Abbott's costs, with the amount to be determined in separate proceedings.
Claims
At issue1
Revokedall
Notes: Paris Local Division revoked EP 3 831 282 entirely for added matter; claim 1 as granted and as amended per AR1, AR2, AR3 all failed; infringement action dismissed for lack of legal basis.